HIV Databases HIV Databases home HIV Databases home
HIV Sequence Database



Download: ENTIRE SEQUENCE SEQUENCE FRAGMENT start end
Format:  
View NCBI entry		Download GenBank file		Graphics View		Download GFF3 File

LOCUS	    AF056135		     540 bp    RNA     linear	VRL 12-JUL-2000
DEFINITION  HIV-1 isolate z1226 from Zimbabwe, envelope glycoprotein V3-V5
	    region (env) pseudogene, partial sequence
ACCESSION   AF056135
VERSION     AF056135.1 GI:3659665
KEYWORDS    .
SOURCE	    Human immunodeficiency virus 1 (HIV-1)
  ORGANISM  Human immunodeficiency virus 1 Viruses; Retro-transcribing viruses;
	    Retroviridae; Orthoretrovirinae; Lentivirus; Primate lentivirus
	    group
REFERENCE   1 (bases 1 to 540)
            Show all sequences for reference 1
  AUTHORS   Batra,M., Tien,P.C., Shafer,R.W., Contag,C.H. and Katzenstein,D.A.
  TITLE     HIV type 1 envelope subtype C sequences from recent seroconverters
	    in Zimbabwe
  JOURNAL   AIDS Res. Hum. Retroviruses 16 (10), 973-979 (2000)
  PUBMED    10890359
REFERENCE   2 (bases 1 to 540)
            Show all sequences for reference 2
  AUTHORS   Batra,M., Tien,P.C., Shafer,R.W., Contag,C.H. and Katzenstein,D.A.
  TITLE     Direct Submission
  JOURNAL   Submitted (30-MAR-1998) Center for AIDS Research, Stanford
	    University School of Medicine, S-156, Stanford, CA 94305, USA
FEATURES             Location/Qualifiers
     source	     1..540
		     /organism="Human immunodeficiency virus 1"
		     /mol_type="genomic RNA"
		     /isolate="z1226"
		     /db_xref="taxon:11676"
		     /country="Zimbabwe"
		     /note="clade C; bulk sequenced reverse transcribed viral
		     RNA from primary PBMC cultures"
     gene	     <1..>540
		     /gene="env"
		     /pseudo="env"
     CDS	     <1..>540
		     /gene="env"
		     /note="envelope glycoprotein; V3-V5 region"
		     /pseudo="envelope glycoprotein; V3-V5 region"
		     /codon_start="1"
		     /transl_table="1"
BASE COUNT	205 a	 101 c	   91 g    143 t
ORIGIN
       1 ataattagct ttgaaaattt gacagacaat gccaaaacaa taatagtaca ttttaataac 
      61 tctgtaacaa ttaagtgtac aagacccagc aataatacaa gaaaaagtat gaggataggg 
     121 ccaggacaaa cattctatgc aacaggagac ataataggag atataagaca agcacattgt 
     181 aacattagtg gcagtgtttg gaacagaact ttacaacagg taggaagaaa attaagagaa 
     241 ctcttcccta ataaaacaat aaaatttaac gcatcctcag ggggggatct agaaattaca 
     301 acacatagct ttaattgtgg aggaaaattt ttctattgca atacatcagg actgtttaat 
     361 agtacataca attctaatta tacagaaaat agtccaaacc ccaacatccc gatcaccctc 
     421 ccatgctgaa taatacaact tattttcatg ttgtgggaag taggacgatc agcgttttcc 
     481 cctcccctca ttagaagaat cacatgttgt tcatctatca tcggacgact atttacgcgt 
//
last modified: Tue May 31 10:56 2022


Questions or comments? Contact us at seq-info@lanl.gov.

 
Operated by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
© Copyright Triad National Security, LLC. All Rights Reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health